You are here: Home: Meet The Professors Vol. 3 Issue 4 2005: Case 2

Case 2: A 52-year-old woman with a one-centimeter, ER/PR-positive, HER2- negative, node-negative breast cancer who has received three years of adjuvant tamoxifen and became amenorrheic in the past year (from the practice of Dr Edmund W Tai)
 

Miller KD et al. E2100: A randomized phase III trial of paclitaxel versus paclitaxel plus bevacizumab as first-line therapy for locally recurrent or metastatic breast cancer. Presentation. ASCO 2005. No abstract available

Miller KD et al. Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer. J Clin Oncol 2005;23(4):792-9. Abstract

 

 

 

 

Table of Contents
 
Home · Contact Us
Terms of Use and General Disclaimer
Copyright © 2005 Research To Practice. All Rights Reserved